tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Aceso Life Science Group Reports Strong Interim Results for 2025

Story Highlights
Aceso Life Science Group Reports Strong Interim Results for 2025

TipRanks Cyber Monday Sale

Aceso Life Science Group Limited ( (HK:0474) ) has shared an update.

Aceso Life Science Group Limited announced its interim results for the six months ending September 30, 2025, reporting a significant turnaround with a profit of HK$384 million compared to a loss of HK$195 million in the previous year. The improvement is attributed to increased revenue from continuing operations and substantial other gains, despite challenges such as fair value losses and administrative expenses.

The most recent analyst rating on (HK:0474) stock is a Hold with a HK$0.13 price target. To see the full list of analyst forecasts on Aceso Life Science Group Limited stock, see the HK:0474 Stock Forecast page.

More about Aceso Life Science Group Limited

Aceso Life Science Group Limited is a company incorporated in the Cayman Islands, operating within the life sciences industry. It focuses on providing innovative solutions and services in the field of life sciences, with a market presence indicated by its listing on the Hong Kong Stock Exchange.

Average Trading Volume: 43,384,650

Technical Sentiment Signal: Buy

Current Market Cap: HK$944.9M

Learn more about 0474 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1